MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mTOR pathway

BACKGROUND: Mitogen‐activated protein kinase 4 (MAPK4) is an atypical member of the mitogen‐activated protein kinase (MAPK) family. We report here that MAPK4 is overexpressed in glioma. The clinical significance, biological roles and underlying molecular mechanisms through which MAPK4 acts in glioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Jing, Zheng, Shijun, Zhang, Lei, Liu, Jia, Cao, Haowei, Wu, Sicheng, Xu, Yixin, Sun, Jinmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242852/
https://www.ncbi.nlm.nih.gov/pubmed/36999945
http://dx.doi.org/10.1002/cam4.5859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242852/
https://www.ncbi.nlm.nih.gov/pubmed/36999945
http://dx.doi.org/10.1002/cam4.5859

Ejemplares similares